Strategic CRO Partnerships Leverage Genelex's long-standing leadership in pharmacogenetics and its patented YouScript decision-support tool to pursue partnerships with CROs and pharmaceutical companies for both clinical and research PGx testing, helping safer drug development and more informed trial outcomes.

Payer ROI Opportunity Position pharmacogenetic testing and YouScript as a patient-safety and cost-reduction solution for payers and health systems, focusing on polypharmacy patients to reduce adverse drug events and optimize prescribing.

EMR Workflow Integration Promote integration of the YouScript platform into physician office workflows and EMR systems, offering licensing or white-label arrangements to enable real-time genotype-guided prescribing.

Pediatric Pain Expansion Explore expansion into pediatric populations and pain management by pursuing partnerships with pediatric care providers and pain clinics, building on past collaborations to address drug-gene interactions in vulnerable groups.

Brand and Trials Leadership Emphasize Genelex as a trusted, long-standing leader in pharmacogenetics to win opportunities with pharma, CROs and health systems, underscoring clinical and research PGx testing and the YouScript platform as differentiators.